Report
Animal Health Market In North America 2025-2029
North America Animal Health Market Outlook (2025–2029)
The animal health market in North America is projected to grow by USD 4.06 billion between 2024 and 2029, registering a CAGR of 4.37%.
This growth is largely fueled by the increasing rate of pet ownership and the rising incidence of animal diseases. The evolving human-animal bond—where pets are considered family members—is prompting demand for better healthcare and wellness solutions for animals. Additionally, the uptick in zoonotic diseases, which can be transmitted from animals to humans, underscores the importance of animal health not only for animals themselves but also for public health.
The industry is rapidly innovating with specialized therapies, including precision medicine, gene editing, and cell-based treatments. These advancements are driving the adoption of advanced diagnostics, preventive care, and companion animal specialty drugs, ensuring both animal and human health are protected.
Market Dynamics
Base Year for Analysis: 2023
A comprehensive evaluation of the drivers, trends, and challenges helps businesses develop strategic marketing initiatives for a competitive edge.
Key Market Drivers
- Rising Pet and Animal Ownership
- Growing numbers of households with pets—especially cats and dogs—are significantly boosting demand.
- Increased consumption of animal-derived products like dairy and eggs contributes to the trend, requiring better health management and yield optimization.
- Biopharmaceutical firms are seizing this opportunity by developing solutions that improve disease prevention and treatment.
- Role of Food-Producing Animals
- Livestock and poultry are vital to both agriculture and public health.
- Veterinarians and ranchers are essential in maintaining animal health to promote sustainable development and efficiency in food production.
- Adoption of Digital Technologies
- Innovations in diagnostics and disease detection are reshaping the industry.
- The sector is addressing concerns like antibiotic resistance by developing alternative treatments and sustainability-focused solutions.
- Animal welfare is a growing concern among both pet owners and livestock farmers, further driving demand for advanced, humane healthcare services.
- Emerging Market Trends
- Focus on Gut Health in Animals
- Awareness is rising about the role of gut health in boosting immunity, bone strength, and protein absorption.
- Biopharma companies are supplying dietary supplements and functional feeds to ranchers to ensure the gut health of livestock, thereby improving productivity and quality.
- Customized Action Plans by Experts
- Veterinarians and animal nutritionists are creating tailored health plans to minimize antibiotic usage and combat antimicrobial resistance.
- Integration of digital health tools and sustainable practices supports better productivity, environmental care, and public safety.
Key Challenges
Antibiotic Resistance
- While antibiotics play a crucial role in disease prevention for livestock, their overuse leads to antimicrobial resistance, posing risks to both animals and humans.
- The industry is focusing on developing digital tools and innovative treatments to minimize reliance on antibiotics while ensuring high yields and quality in food production.
- Collaboration among stakeholders—including ranchers, veterinarians, and pharmaceutical companies—is essential for promoting responsible use of antimicrobials and securing food safety and sustainability.
Key Companies and Competitive Landscape
Major players are adopting strategies such as partnerships, mergers and acquisitions, regional expansions, and product innovations to strengthen their market presence.
Leading Companies Include:
- American Animal Health Inc.
- Alltech Inc.
- Bimeda Holdings Ltd.
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Eco Animal Health Group Plc
- Elanco Animal Health Inc.
- Huvepharma EOOD
- Mars Inc.
- Merck & Co. Inc.
- Patterson Companies, Inc.
- Phibro Animal Health Corp.
- Thermo Fisher Scientific Inc.
- Vetio
- Virbac SA
- Zoetis Inc.
Company Analysis:
A combination of qualitative and quantitative evaluation categorizes these companies by business focus (pure play, industry-focused, etc.) and market strength (dominant, strong, tentative, etc.), offering valuable insights into the competitive environment.
TABLE OF CONTENTS
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Country Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Animal Type
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis
3 Market Sizing
3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2025
3.4 Market outlook: Forecast for 2025-2029
- Chart on North America - Market size and forecast 2025-2029 ($ million)
- Data Table on Regional - Market size and forecast 2025-2029 ($ million)
- Chart on North America: Year-over-year growth 2025-2029 (%)
- Data Table on Regional - Market size and forecast 2025-2029 ($ million)
4 Historic Market Size
4.1 Animal Health Market in North America 2022 - 2024
- Historic Market Size - Data Table on Animal Health Market in North America 2022 – 2024
($ million)
4.2 Animal Type segment analysis 2022 - 2024
- Historic Market Size - Animal Type Segment 2022 - 2024 ($ million)
4.3 Product segment analysis 2022 - 2024
- Historic Market Size - Product Segment 2022 - 2024 ($ million)
4.4 Geography segment analysis 2022 - 2024
- Historic Market Size - Geography Segment 2022 - 2024 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2029
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2029
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2029
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2029
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2029
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2029
5.7 Market condition
- Chart on Market condition - Five forces 2025 and 2029
6 Market Segmentation by Animal Type
6.1 Market segments
- Chart on Animal Type - Market share 2025-2029 (%)
- Data Table on Animal Type - Market share 2025-2029 (%)
6.2 Comparison by Animal Type
- Chart on Comparison by Animal Type
- Data Table on Comparison by Animal Type
6.3 Livestock - Market size and forecast 2025-2029
- Chart on Livestock - Market size and forecast 2025-2029 ($ million)
- Data Table on Livestock - Market size and forecast 2025-2029 ($ million)
- Chart on Livestock - Year-over-year growth 2025-2029 (%)
- Data Table on Livestock - Year-over-year growth 2025-2029 (%)
6.4 Companion animals - Market size and forecast 2025-2029
- Chart on Companion animals - Market size and forecast 2025-2029 ($ million)
- Data Table on Companion animals - Market size and forecast 2025-2029 ($ million)
- Chart on Companion animals - Year-over-year growth 2025-2029 (%)
- Data Table on Companion animals - Year-over-year growth 2025-2029 (%)
6.5 Market opportunity by Animal Type
- Market opportunity by Animal Type ($ million)
- Data Table on Market opportunity by Animal Type ($ million)
7 Market Segmentation by Product
7.1 Market segments
- Chart on Product - Market share 2025-2029 (%)
- Data Table on Product - Market share 2025-2029 (%)
7.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
7.3 Pharmaceutical - Market size and forecast 2025-2029
- Chart on Pharmaceutical - Market size and forecast 2025-2029 ($ million)
- Data Table on Pharmaceutical - Market size and forecast 2025-2029 ($ million)
- Chart on Pharmaceutical - Year-over-year growth 2025-2029 (%)
- Data Table on Pharmaceutical - Year-over-year growth 2025-2029 (%)
7.4 Feed additive - Market size and forecast 2025-2029
- Chart on Feed additive - Market size and forecast 2025-2029 ($ million)
- Data Table on Feed additive - Market size and forecast 2025-2029 ($ million)
- Chart on Feed additive - Year-over-year growth 2025-2029 (%)
- Data Table on Feed additive - Year-over-year growth 2025-2029 (%)
7.5 Biologicals - Market size and forecast 2025-2029
- Chart on Biologicals - Market size and forecast 2025-2029 ($ million)
- Data Table on Biologicals - Market size and forecast 2025-2029 ($ million)
- Chart on Biologicals - Year-over-year growth 2025-2029 (%)
- Data Table on Biologicals - Year-over-year growth 2025-2029 (%)
7.6 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
- Chart on Market share by geography - 2025-2029 (%)
- Data Table on Market share by geography - 2025-2029 (%)
9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
9.3 US - Market size and forecast 2025-2029
- Chart on US - Market size and forecast 2025-2029 ($ million)
- Data Table on US - Market size and forecast 2025-2029 ($ million)
- Chart on US - Year-over-year growth 2025-2029 (%)
- Data Table on US - Year-over-year growth 2025-2029 (%)
9.4 Canada - Market size and forecast 2025-2029
- Chart on Canada - Market size and forecast 2025-2029 ($ million)
- Data Table on Canada - Market size and forecast 2025-2029 ($ million)
- Chart on Canada - Year-over-year growth 2025-2029 (%)
- Data Table on Canada - Year-over-year growth 2025-2029 (%)
9.5 Mexico - Market size and forecast 2025-2029
- Chart on Mexico - Market size and forecast 2025-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2029 (%)
- Data Table on Mexico - Year-over-year growth 2025-2029 (%)
9.6 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Table on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2029
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
- Overview on factors of disruption
11.4 Industry risks
- Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
- Companies covered
12.2 Market positioning of companies
- Matrix on companies position and classification
12.3 American Animal Health Inc
- American Animal Health Inc. - Overview
- American Animal Health Inc. - Product / Service
- American Animal Health Inc. - Key offerings
12.4 Alltech Inc.
- Alltech Inc. - Overview
- Alltech Inc. - Product / Service
- Alltech Inc. - Key news
- Alltech Inc. - Key offerings
12.5 Bimeda Holdings Ltd.
- Bimeda Holdings Ltd. - Overview
- Bimeda Holdings Ltd. - Product / Service
- Bimeda Holdings Ltd. - Key offerings
12.6 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
12.7 Ceva Sante Animale
- Ceva Sante Animale - Overview
- Ceva Sante Animale - Product / Service
- Ceva Sante Animale - Key offerings
12.8 Eco Animal Health Group Plc
- Eco Animal Health Group Plc - Overview
- Eco Animal Health Group Plc - Product / Service
- Eco Animal Health Group Plc - Key offerings
12.9 Elanco Animal Health Inc.
- Elanco Animal Health Inc. - Overview
- Elanco Animal Health Inc. - Product / Service
- Elanco Animal Health Inc. - Key offerings
12.10 Huvepharma EOOD
- Huvepharma EOOD - Overview
- Huvepharma EOOD - Product / Service
- Huvepharma EOOD - Key offerings
12.11 Mars Inc.
- Mars Inc. - Overview
- Mars Inc. - Product / Service
- Mars Inc. - Key news
- Mars Inc. - Key offerings
12.12 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
12.13 PATTERSON COMPANIES, INC.
- PATTERSON COMPANIES, INC. - Overview
- PATTERSON COMPANIES, INC. - Business segments
- PATTERSON COMPANIES, INC. - Key offerings
- PATTERSON COMPANIES, INC. - Segment focus
12.14 Phibro Animal Health Corp.
- Phibro Animal Health Corp. - Overview
- Phibro Animal Health Corp. - Business segments
- Phibro Animal Health Corp. - Key news
- Phibro Animal Health Corp. - Key offerings
- Phibro Animal Health Corp. - Segment focus
12.15 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
12.16 Virbac SA
- Virbac SA - Overview
- Virbac SA - Business segments
- Virbac SA - Key offerings
- Virbac SA - Segment focus
12.17 Zoetis Inc.
- Zoetis Inc. - Overview
- Zoetis Inc. - Business segments
- Zoetis Inc. - Key news
- Zoetis Inc. - Key offerings
- Zoetis Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
13.3 Currency conversion rates for US$
- Currency conversion rates for US$
13.4 Research methodology
- Research methodology
13.5 Data procurement
- Information sources
13.6 Data validation
- Data validation
13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
13.8 Data synthesis
- Data synthesis
13.9 360 degree market analysis
- 360 degree market analysis
13.10 List of abbreviations
- List of abbreviations
Research Methodology
All our research reports employ a mixed-methods approach, leveraging both primary and secondary research techniques to develop a comprehensive and well-informed analysis. The methodology ensures a balanced perspective by combining data-driven insights with expert opinions.
1. Secondary Research
Secondary research formed the foundation of the study, offering a contextual understanding of the market landscape, historical trends, and existing data. This phase involved gathering and analyzing information from:
- Industry reports and whitepapers (e.g., McKinsey, Deloitte, Statista)
- Academic journals and case studies
- Company reports, investor presentations, and press releases
- Government databases and regulatory publications
- Trade publications, industry blogs, and news articles
2. Primary Research
To validate and complement secondary findings, extensive primary research was conducted. This included both quantitative data collection and qualitative insights, particularly through expert consultations.
a. Expert Consultations (Qualitative Primary Research)
In-depth interviews were conducted with a wide range of industry stakeholders, including:
- Industry experts and consultants
- Senior executives and decision-makers
- Product managers and supply chain professionals
- Academic researchers and analysts
b. Surveys and Questionnaires (Quantitative Primary Research)
Structured surveys were distributed among:
- End-users/consumers
- Retailers and distributors
- Business-to-business (B2B) buyers
3. Data Validation and Triangulation
Findings from secondary and primary sources were cross-validated through data triangulation to ensure accuracy, consistency, and reliability. This process involved comparing insights from different sources and reconciling discrepancies through expert feedback.
4. Analytical Tools and Frameworks
Various analytical models were applied to interpret the collected data:
- SWOT Analysis for understanding strengths, weaknesses, opportunities, and threats
- Porter’s Five Forces to assess market competitiveness
- PESTLE Analysis to evaluate external macroeconomic influences
- Forecasting Models using historical data trends and regression analysis
Conclusion
The combination of comprehensive secondary research and robust primary data collection—enhanced by expert consultations—ensured the development of a well-rounded and in-depth analysis. This approach enables strategic decision-making backed by both empirical evidence and industry expertise.
For detailed methodology for this particular report please write to us on info@syovi.com